NabilMAhmedMD

PubMed

• A checkpoint reversal receptor mediates bipartite activation and enhances CAR T-cell function.
  Daniel Landi, Shoba A Navai, Rebecca M Brock, Kristen Fousek, Zeid Nawas
  Cancer Research Communications. 2025-02-20
• ZP4: A Novel Target for CAR T Cell Therapy in Triple Negative Breast Cancer.
  Lauren K Somes, Jonathan T Lei, Xinpei Yi, Diego F Chamorro, Paul Shafer
  Molecular Therapy. 2025-02-20
• Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors.
  Aaron B Ross, Kriti Puri, Thomas L Johnson, Lilliam D Correa, Tami D John
  Pediatric Blood & Cancer. 2025-01-20

Journal Articles

• Retraction Note: A Homing System Targets Therapeutic T Cells to Brain Cancer  
  Nabil Ahmed, Fong W Lam, Meenakshi Hegde, Jordan S Orange, Thomas Shum, Rakesh K Jain, Nature

Abstracts/Posters

• Cell Adhesion of ALL to Stromal Cells May Mediate CAR T-Cell Resistance: A Novel Escape Mechanism for Immunotherapy
  Nabil Ahmed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Other

• Evaluation and management of fever in children with non-chemotherapy-induced neutropenia 
  Ahmed NM, Palazzi DL
  http://www.uptodate.com/contents/evaluation-and-management-of-fever-in-children-with-non-chemotherap
  UpToDate, Wolters Kluwer Health - 2013-01-02
• Risk of infection in children with fever and non-chemotherapy-induced neutropenia 
  Ahmed NM, Palazzi DL
  http://www.uptodate.com/contents/risk-of-infection-in-children-with-fever-and-non-chemotherapy-induc
  UpToDate, Wolters Kluwer Health - 2013-04-16
• Fever in children with chemotherapy-induced neutropenia 
  Ahmed NM, Flynn PM
  http://www.uptodate.com/contents/fever-in-children-with-chemotherapy-induced-neutropenia
  UpToDate, Wolters Kluwer Health - 2013-01-07